Summary. The synthesis of glycosylated haemoglobins in vivo was measured during 24 h of controlled hyperglycaemia in seven insulin dependent diabetics. The mean blood glucose concentration was 22 mmol/1, while electrolytes and other metabolites were kept normal by infusion of 4-23 IU of insulin during hyperglycaemia. The study confirmed the velocity and magnitude of unstable HbAlc formation previously found in vitro. The stable HbA~ formed in 24 h was on average 0.006% of total haemoglobin/ mmol glucose. This compares well with the rate of HbAI~ synthesis reported in normal subjects using 59Fe-kinetic measurements, and is in accordance with the concept of slow changes in stable HbAlo with time and glucose concentration. To investigate the possibility that the rate of HbAlc synthesis varies with erythrocyte age, glycosylated haemoglobins were measured in erythrocyte fractions after density separation on Percoll-Albumin gradients. We found both in normal subjects and in insulin treated diabetics that the 5% least dense cells contained 70%-80% of whole blood HbAlc. Assuming the least dense cells to be the youngest erythrocytes, this observation is inconsistent with a slow linear increase in HbAIo. Similar results were obtained in six newly diagnosed insulin dependent diabetic patients both before and after the first 30 days of insulin treatment, even though a marked decrease in young cell HbA]c would be expected with the improved glucose control observed. We therefore conclude that density separation of erythrocytes is an inadequate technique to study age related HbAlo synthesis.
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In subjects with constantblood glucose levels, clinical studies have confirmed that the concentration of haemoglobin Ale (HbAlc) is proportional to fasting or mean blood glucose concentrations [1, 2] . Recent reports of rapid changes in the aldimine precursor of stable HbAlo and of its co-determination in chromatographic methods [3] [4] [5] may eventually help to clarify the connection between mean blood glucose and stable HbAI~ in subjects with unstable glucose levels, i. e. in insulin-treated insulin-dependent diabetic patients. The rational use of HbA1~ in clinical assessment of long-term glycaemic control needs to be based on knowledge of rates of synthesis and dissociation of glycosylated haemoglobins. Hitherto few reports have considered this problem.
Using 59-Fe-labelled HbA, Bunn et al. [6] found 24 h synthesis to be in the order of 0.01% HbAlo/ mmol glucose in vivo in two normal subjects. Using a first order kinetic model, Beach [7] calculated the observed rate to be consistent with data for total glycosylated haemoglobins (HbAt) and glucose concentrations reported in the literature. From the model, Beach also concluded that about one-quarter of average erythrocyte HbAlc might be present when new erythrocytes are released into the circulation. In contrast, Labie et al. [8] reported absence of HbAlo in erythroblasts, but like Fitzgibbons et al. [9] he found a relatively large proportion of average erythrocyte HbAlc to be present in the 10% least dense eryhtrocytes, supposed to be the 10% youngest cells, separated by density gradient centrifugation. Recently, in a group of insulin independent diabetic patients, Boden et al. [10] reported an increase in total HbAI of 1.5% in 7 days following a mean increase in fasting plasma glucose of 2.2 mmol/1. This represents a 24 h synthesis close to 0.1% HbAl/mmol glucose increment.
Such differences in synthesis of glycosylated haemoglobins in vivo clearly create doubts about the 0019-186X/81/0021/0549/$01.00 clinical interpretation of HbAlc results as indicators of long-term glycaemic control in diabetics.
Therefore our study was undertaken: (1) to determine HbAlo synthesis during a 24 h period of controlled hyperglycaemia, and (2) to measure glycosylated haemoglobins in density separated erythrocytes, evaluating this technique as a means of studying time relations in haemoglobin glycosylation. in 2-3 h. Normoglycaemia was maintained for a further 6 h before the end of the experiment.
During the experiment the patients had their usual diets and performed ergometer cycling for exercise if desired. Starting 2 h before induction of hyperglycaemia, blood was sampled every 2 h for determination of glycosylated haemoglobins, electrolytes, non-esterified fatty acids (NEFA) and 3-hydroxybutyrate. During hyperglycaemia all samPles were screened for ketone bodies using Ketostix. Total HbAlo was determined in all samples, and iA,c by quadruplicate determinations in samples collected 0, 16, 24 and 32 h after induction of hyperglycaemia.
Materials and Methods

Glycosylated Haemoglobins
Chromatographic determination of glycosylated haemoglobin fractions (HbAl,+b and HbAlc) was performed as previously described [5] . The range determined in normal controls was 4.1%-6.4% of total haemoglobin (mean _+ 2 SD). Total HbAIo and HbAja+b (tAlc and tAla+b) were determined after a maximum of 24 h storage of heparinized whole blood samples at 4 ~ Stable HbAla+b and HbAIo (incubated fractions = iAi,+b, iAlc) were measured after a 6 h incubation at 37 ~ C of blood samples diluted in 0.15 mol/1 saline [5] .
The thiobarbiturate method as modified by Pecoraro et al. [11] was used to determine ketoamine-bound glucose in haemolysates. Saline-washed erythrocytes were used for preparation ofhaemolysates with a haemoglobin concentration of 0.625 mmol/1. For control of the thiobarbiturate method, a 100 ~tmol/1 fructose solution was determined in each assay, and mean absorbance at 443 nm was 0.170 with a day-to-day coefficient of variation of 2%.
Blood glucose concentration was determined by a modification of the Trinder glucose oxidase method [12] . Plasma sodium, potassium and bicarbonate (pCO2 = 40 mmHg) were determined by standard clinical chemistry procedures, plasma non-esterified fatty acids (NEFA) by colorimetry [13] and 3-hydroxybutyrate enzymatically [14] .
HbAlc Synthesis In Vivo
Seven insulin-dependent diabetic in-patients (one female, six males) were carefully instructed about the nature of the investigation before giving their consent to participate. Their mean age was 32 years (range 20M4 years), and the duration of diabetes 1-23 years. During SC insulin therapy they received a daily dose of insulin of 0.40 UI/kg (range 0.144).65 IU/kg). Body weight was within 82%-118% (mean 99%) of ideal body weight. The mean of five blood glucose determinations during the 24 h before connection to the artificial betacell ranged from 4.0 to 12.5 mmol/1 (mean 8.4 mmol/1).
After connection to the artificial betacell (Biostator), normoglycaemia of 5-6 mmol/1 was maintained for at least 6 h before induction of hyperglycaemia by oral ingestio n of 100 g of D-glucose, supplemented by IV infusion of glucose by the Biostator to maintain a blood glucose concentration of approximately 22 mmol/1. An extra 25 g of glucose were given orally whenever blood glucose fell below 18 mmol/1. At a blood glucose concentration of 22 mmol/1, the patients received an infusion of insulin 0.01 1U/rain. Supplementary insulin was infused when blood glucose exceeded 22 mmol/1 or if plasma ketone bodies increased (Ketostix).
Hyperglycaemia was terminated after 24 h by reprogramming the Biostator to maintain a blood glucose concentration of 4.5 mmol/1, and normoglycaemia was reached in all patients with-
Density Separation of Erythroeytes
Density separation of erythrocytes was carried out on Percoll-albumin gradients as described and evaluated by Rennie et al. [15] , starting the separation procedure within 2 h of blood collection. For each sample exploratory gradients, usually containing 57%-65% Percoll, were run to find the density mixture leaving fewer than 10% of the cells in the upper layer. This mixture was used for preparation from 0.5 ml whole blood aliquots of sufficient 'low density cells' for counting and determination of glycosylated haemoglobin fractions.
The numbers of erythrocytes applied to the density mixture and recovered from the upper layer after centrifugation were counted, and the reticulocyte fraction was determined both in whole blood and in the 'low density cells'. Both whole blood and low density cells were incubated in glucose 2 mmol/1 in saline 0.15 tool/1 for 6 h at 37 ~ before preparation of haemolysates for determination of stable glycosylated haemoglobins. All chromatographic determinations were performed in duplicate. Blood for density separation of erythrocytes was obtained from: (1) eight consecutive insulin dependent diabetic out-patients; (2) six non-diabetic volunteers from the hospital staff; and (3) six consecutive newly diagnosed diabetics both before and 31-35 days after the start of insulin treatment.
The newly diagnosed diabetics were all admitted to the hospital with mild to moderate ketonuria, but without acidosis (standard bicarbonate 19-24 mmol/l). All six were males aged 14-26 years and having a body weight of 82%-96% of ideal body weight. At admission they had blood glucose values from 16 to 24 mmol/1 and excreted 53-115 g glucose in the urine during the first 24 h. They stayed as in-patients for 10-14 days and on discharge were treated with 18~40 IU insulin/day. During the last three days in hospital, the mean blood glucose values ranged from 7.0 to 12.8 mmol/l (mean 9.1 mmol/1). At the first visit to the out-patient clinic, 31-35 days after start of the insulin treatment, their fasting blood glucose values ranged from 5.0 to 13.8 mmol/1 (mean 7.7 mmol/1).
Results are given as mean values + SEM. Student's 't; test and Wilcoxons rank sum test were used for statistical calculations.
Results
To maintain a hyperglycaemia of 22 mmol/1 the patients received on average 503 g of glucose (range 312-1145 g) and excreted 319 g (approximately 63%) in the urine. A mean dose of 15 IU insulin (range 4-23 ILl) was infused during the hyperglycaemic period.
The results for increases in total HbAlc (tAlo), stable HbAlc (iAlo) and blood glucose concentrations are shown in Figure 1 . Before induction of hyperglycaemia, stable HbAlc ranged from 5.5% to 10.5% of to- tal haemoglobin (mean 7.9%). Total HbAI~ increased significantly 2 h after induction of hyperglycaemia (0.84 + 0.22%) and reached a stable level within 4-6 h. During the rest of the hyperglycaemic period no significant changes in tA~o were observed. The mean increase was 1.28 _+ 0.05% and range of observed increases 0.88% to 2.06% of total haemoglobin. After return of blood glucose to normal the tAlc concentration decreased to a level 0.17% + 0.04% higher than before hyperglycaemia (2p < 0.05). At 16 and 24 h iAlo was 0.09 _+ 0.05% and 0.13 _+ 0.07% higher than before hyperglycaemia. At 24 h this increase in iAlc was statistically significant in five of seven patients. Six hours after return of blood glucose to normal, iAl~ was 0.10 + 0.04% higher than before hyperglycaemia. During hyperglycaemia, blood glucose concentrations were on average 22.2 __ 0.03 mmol/1 and accordingly the average production of stable HbAlc in 24 h was 0.006%/mmol glucose. Results for HbAl~+b and thiobarbiturate reactive material are given in Table 1 ; iAla+b showed a significant increase (2p < 0.05) in six of seven patients in response to hyperglycaemia, which was sustained after return of blood glucose to normal. In the thiobarbiturate assay, the relative increase in absorbance from before to after hyperglycaemia was close to that ofiAl~. No significant changes were noted in plasma potassium or bicarbonate (range 3.%5.1 and 22.3-28.5 ram 9 respectively). During hyperglycaemia three patients had episodes of increased lipolysis and ketogenesis. The highest 3-hydroxybutyrate concentrations determined in these patients were 1.7, 1.2 and 0.6 mmol/1, and in all three they returned to normal within a few hours after the infusion of supplementary insulin. Otherwise NEFA and 3-hydroxybutyrate values ranged from 70 to 960 and 40 to 560 ~tmol/1, respectively.
Density Separation
Results for iAlc in density-separated erythrocytes and whole blood are shown in Table 2 . The concentration of iAlc in unfractionated samples from out-patient insulin-dependent diabetics ranged from 6.4% to 10.3%, in normal samples from 4:9% to 5.4% and in newly diagnosed diabetics from 10.1% to 17.5% before insulin treatment and from 8.6% to 12.3% after 31-35 days of insulin treatment. The percentage of erythrocytes recovered in the 'low density' fraction ranged from 2.1% to 9.5% of the erythrocytes applied to the density mixture, and the reticulocyte fraction was four to ten times higher in the low density cells. The mean ratio of HbAla+b or HbAlc concentration in the low density cells to that in whole blood did not differ significantly between normal subjects and diabetics. None had ratios above 1.0, and for HbAlo the lowest ratio determined was 0.66 and 0.69 in normal and diabetic samples respectively. Using the thiobarbiturate method Results are expressed as mean + SEM a on average 5.4% of the erythrocytes applied to the density gradient were recovered in the upper, less dense cell fraction (range 2.1% to 9.5%) u same patients 31-35 days after start of insulin treatment the ratio of absorbance in low density cells to that in whole blood was 0.90 + 0.02 in six of the insulin dependent diabetic samples.
Discussion
Qualitatively, the changes in the unstable HbA1c fraction observed during a 24 h period of induced hyperglycaemia in our diabetic patients closely resemble those previously reported from incubation of erythrocytes in glucose-containing media in vivo [5] . Thus, during a squarewave glucose profile in vivo, total HbAlc reached a new stable level within 6 h of the increase in blood glucose concentration, and the increment nearly disappeared during the subsequent period of normoglycaemia. Quantitatively, total HbAlc increased by 0.058% of total Hb/mmol glucose in vivo, and this is only slightly more than the 0.045%/mmol glucose found after incubation of erythrocytes in vitro. From the correlation we previously reported between the unstable HbA~o fraction and the actual blood glucose concentration in out-patient diabetics [5] , an increase of 1.08% talc was expected, and this is not significantly different from the 1.28% observed.
The average production of stable HbA~, 0.006%/ mmol glucose during a 24 h hyperglycaemic period, was comparable to the 0.009%/mmol glucose calculated from the rate constant in vivo reported by Bunn et al. [6] using the model proposed by Beach [7] , but lower than the 0.013%/mmol glucose we previously found after incubation of erythrocytes in glucose 100 mmol/1 saline. In contrast, the observed production of HbAlc was an order of magnitude lower than that reported by Boden et al. [10] during the first week of deteriorated glucose control in insulin-independent patients. This difference persists even if the latter results are corrected for possible co-determination of 0.2%q).4% unstable HbA~ formed during a 2-5 mmol/l blood glucose increment. The reason for these differences is not known. Further, little is known at present about the influence of hormonal and metabolic factors on the glucose-haemoglobin interaction in vivo. In this study, the metabolic conditions -except for glucose -were fairly normal, and differences between erythrocyte and general metabolism may partly explain the reported differences in haemoglobin glycosylation in vivo, and the observed differences between synthesis in vitro and that in vivo found by us.
The results for density-separated erythrocytes show that both in normal and diabetic subjectswhether controlled or newly diagnosed -the 5% least dense cells contained 70%-80% of mean cell HbAlc, and the thiobarbiturate assay results confirmed the presence of a high fraction of ketoamine-bound glucose in the less dense cell fraction. Our mean ratios of HbAlo in low density cells to whole blood HbAlo are slightly higher than the 66% in normal subjects and 60% in diabetics calculated from the data reported by Fitzgibbons et al. [9] , who separated the 10% least dense cells. However, all our subjects have ratios within the ranges calculated from data of Fitzgibbon et al. In close agreement with our data, Labie [8] recently reported the major proportion of HbAIo to be present in the 5% least dense cells. LaNe also reported absence of glycosylated haemoglobins in erythroblasts from the bone marrow, whereas Beach [7] from model studies postulated that HbA~ might be present in new erythrocytes entering the circulation.
The validity of density separation as a method for age separation of erythrocytes has been based mainly upon differences in enzyme, haemoglobin and electrolyte concentrations in the density-separated cells [1 5] . Recently Luthra et al. [1 6] , using 59Fe-labelling of haemoglobin in vivo, showed that although young erythrocytes tended to concentrate in the least dense cell fractions, a substantial fraction of the young erythrocytes rapidly achieved different densities and consequently distributed nearly uniformly throughout a density gradient.
If the proposed slow, nearly linear increase in HbAlc during erythrocyte life span is correct, two major discrepancies in our results for HbAlc in densityseparated erythrocytes need to be resolved. First, if density separation resulted in age separation the 5% least dense and youngest cells should contain less than 10% of mean cell or whole blood HbAlc, whereas 70%-80% was found in all groups investigated. Secondly, the ratio of HbAlc in young cells to whole blood was expected to decrease to less than one half after a 30 day period of improved control in the group of newly diagnosed diabetics. No decrease in the ratio was found although whole blood HbAlo showed a substantial decrease. The second discrepancy, unlike the first, cannot be explained by postulating either that the hyperglycaemic period before improved control lasted less than the usual 120 day erythrocyte life span, or alternatively that there was some dissociation of circulating HbAlo.
Most clinical studies have reported a significant correlation between glycosylated haemoglobins and measures of glucose control. This proves glucose to be a major determinant, but not necessarily the only one, for the formation of HbAI~. Thus, it has recently been reported that iron deficiency [17] and nephropathy [18] per se increased the HbAI~ concentration, and other factors influencing synthesis and Stability of HbA1c may come to light.
A low rate of HbAlc synthesis has been described in this and other studies for normal subjects and diabetics having a fairly constant blood glucose concentration, but prediction of HbAI~ concentrations in diabetics showing widely varying glucose values from such data may be difficult. In this context it is still uncertain whether identical mean blood glucose concentrations with different amplitudes of excursions around the mean will provide identical concentrations of glycosylated haemoglobins.
There is clearly a need for further studies on the rate of formation of aldimine HbAI~ and its conversion to ketoamine HbAIo and on factors influencing this process, before complete understanding of the relationship between HbAI~ and glucose control in diabetics can be achieved.
